13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001637946
Total reported value
$188.5M
$188.5M
8 檔
1579.9%
At the close of Q3 2025, General Catalyst Group Management, LLC disclosed equity holdings valued at approximately $188.5M, spread across 8 reported holdings.
In Q3 2025, General Catalyst Group Management, LLC adopted a defensive or profit-taking posture, trimming 1 positions and completely liquidating 6 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRCL | Circle Internet Group Inc | Stock-Financials | 82.89% | — | -5.57% | |
| 2 | IOT | Samsara Inc-cl A | Stock-Tech | 11.34% | -34.53% | EXIT | |
| 3 | FIG | Figma Inc-cl A | Stock-Other | 1.50% | -0.03% | — | |
| 4 | GTLB | Gitlab Inc-cl A | Stock-Tech | 1.37% | -10.86% | EXIT | |
| 5 | AVBP | Arrivent Biopharma Inc | Stock-Other | 0.91% | +8.76% | — | |
| 6 | MAZE | Maze Therapeutics Inc | Stock-Other | 0.88% | -0.45% | — | |
| 7 | CART | Maplebear Inc | Stock-Consumer Disc | 0.86% | +3.35% | — | |
| 8 | GUTS | Fractyl Health Inc | Stock-Other | 0.26% | +0.84% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MAZE | Maze Therapeutics Inc | -0.4% | — | Unchanged |
| 2 | AVBP | Arrivent Biopharma Inc | -2.2% | — | Unchanged |
| 3 | CART | Maplebear Inc | -2.3% | — | Unchanged |
| 4 | GTLB | Gitlab Inc-cl A | -3.5% | — | Unchanged |
| 5 | IOT | Samsara Inc-cl A | -64% | -22.79% | Trim |
| 6 | CRCL | Circle Internet Group Inc | — | NEW | New buy |
| 7 | FIG | Figma Inc-cl A | — | NEW | New buy |
| 8 | SNOW | Snowflake Inc | — | EXIT | Sold out |
| 9 | EVLV | Evolv Technologies Holdings | — | EXIT | Sold out |
| 10 | OSCR | Oscar Health Inc - Class A | — | EXIT | Sold out |
| 11 | GUTS | Fractyl Health Inc | — | NEW | New buy |
| 12 | CMRC | Commerce.com Inc | — | EXIT | Sold out |
| 13 | PETXQ | Wag! Group Co | — | EXIT | Sold out |
| 14 | VRMUSD | Vroom Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, General Catalyst Group Management, LLC reported a total U.S. public equity portfolio value of $188.5M across 8 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including CRCL, IOT, FIG) accounted for 1579.9% of total reported equity market value during Q3 2025.
Top New Position Initiated
CRCL
市值: $2.5B
Top Position Liquidated / Trimmed
SNOW
前期市值: $38.7M
During Q3 2025, General Catalyst Group Management, LLC's top holdings by market value included CRCL (82.9%)、IOT (11.3%)、FIG (1.5%). The largest single position, CRCL, represented 82.9% of total portfolio value.
In Q3 2025, General Catalyst Group Management, LLC made 10 total portfolio adjustments, initiating 3 new buys, adding to 0 positions, trimming 1 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.